242 related articles for article (PubMed ID: 37625799)
1. Evaluation of inflammatory cytokines in drug-naïve major depressive disorder: A systematic review and meta-analysis.
Islam MR; Sohan M; Daria S; Masud AA; Ahmed MU; Roy A; Shahriar M
Int J Immunopathol Pharmacol; 2023; 37():3946320231198828. PubMed ID: 37625799
[No Abstract] [Full Text] [Related]
2. Effects of SSRIs on peripheral inflammatory markers in patients with major depressive disorder: A systematic review and meta-analysis.
Wang L; Wang R; Liu L; Qiao D; Baldwin DS; Hou R
Brain Behav Immun; 2019 Jul; 79():24-38. PubMed ID: 30797959
[TBL] [Abstract][Full Text] [Related]
3. Peripheral levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and interleukin-1β across the mood spectrum in bipolar disorder: A meta-analysis of mean differences and variability.
Solmi M; Suresh Sharma M; Osimo EF; Fornaro M; Bortolato B; Croatto G; Miola A; Vieta E; Pariante CM; Smith L; Fusar-Poli P; Shin JI; Berk M; Carvalho AF
Brain Behav Immun; 2021 Oct; 97():193-203. PubMed ID: 34332041
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression.
Passos IC; Vasconcelos-Moreno MP; Costa LG; Kunz M; Brietzke E; Quevedo J; Salum G; Magalhães PV; Kapczinski F; Kauer-Sant'Anna M
Lancet Psychiatry; 2015 Nov; 2(11):1002-12. PubMed ID: 26544749
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Markers of central inflammation in major depressive disorder: A systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue.
Enache D; Pariante CM; Mondelli V
Brain Behav Immun; 2019 Oct; 81():24-40. PubMed ID: 31195092
[TBL] [Abstract][Full Text] [Related]
7. Effects of antidepressant drug therapy with or without physical exercise on inflammatory biomarkers in major depressive disorder: a systematic review and meta-analysis of randomized controlled trials.
Fernandes BM; Scotti-Muzzi E; Soeiro-de-Souza MG
Eur J Clin Pharmacol; 2022 Mar; 78(3):339-349. PubMed ID: 34708271
[TBL] [Abstract][Full Text] [Related]
8. Association of normal weight obesity phenotype with inflammatory markers: A systematic review and meta-analysis.
Mohammadian Khonsari N; Baygi F; Tabatabaei-Malazy O; Mohammadpoor Nami S; Ehsani A; Asadi S; Qorbani M
Front Immunol; 2023; 14():1044178. PubMed ID: 36923417
[TBL] [Abstract][Full Text] [Related]
9. Altered peripheral blood compounds in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis.
Çakici N; Sutterland AL; Penninx BWJH; Dalm VA; de Haan L; van Beveren NJM
Brain Behav Immun; 2020 Aug; 88():547-558. PubMed ID: 32330592
[TBL] [Abstract][Full Text] [Related]
10. Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis.
Liu JJ; Wei YB; Strawbridge R; Bao Y; Chang S; Shi L; Que J; Gadad BS; Trivedi MH; Kelsoe JR; Lu L
Mol Psychiatry; 2020 Feb; 25(2):339-350. PubMed ID: 31427752
[TBL] [Abstract][Full Text] [Related]
11. The Association Between Adverse Childhood Experiences and Inflammation in Patients with Major Depressive Disorder: A Systematic Review.
Gill H; El-Halabi S; Majeed A; Gill B; Lui LMW; Mansur RB; Lipsitz O; Rodrigues NB; Phan L; Chen-Li D; McIntyre RS; Rosenblat JD
J Affect Disord; 2020 Jul; 272():1-7. PubMed ID: 32379599
[TBL] [Abstract][Full Text] [Related]
12. Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies.
Köhler CA; Freitas TH; Maes M; de Andrade NQ; Liu CS; Fernandes BS; Stubbs B; Solmi M; Veronese N; Herrmann N; Raison CL; Miller BJ; Lanctôt KL; Carvalho AF
Acta Psychiatr Scand; 2017 May; 135(5):373-387. PubMed ID: 28122130
[TBL] [Abstract][Full Text] [Related]
13. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression.
Liu Y; Ho RC; Mak A
J Affect Disord; 2012 Aug; 139(3):230-9. PubMed ID: 21872339
[TBL] [Abstract][Full Text] [Related]
14. Elevated specific peripheral cytokines found in major depressive disorder patients with childhood trauma exposure: a cytokine antibody array analysis.
Lu S; Peng H; Wang L; Vasish S; Zhang Y; Gao W; Wu W; Liao M; Wang M; Tang H; Li W; Li W; Li Z; Zhou J; Zhang Z; Li L
Compr Psychiatry; 2013 Oct; 54(7):953-61. PubMed ID: 23639406
[TBL] [Abstract][Full Text] [Related]
15. Alteration patterns of peripheral concentrations of cytokines and associated inflammatory proteins in acute and chronic stages of schizophrenia: a systematic review and network meta-analysis.
Halstead S; Siskind D; Amft M; Wagner E; Yakimov V; Shih-Jung Liu Z; Walder K; Warren N
Lancet Psychiatry; 2023 Apr; 10(4):260-271. PubMed ID: 36863384
[TBL] [Abstract][Full Text] [Related]
16. Altered serum TNF-α and MCP-4 levels are associated with the pathophysiology of major depressive disorder: A case-control study results.
Nayem J; Sarker R; Roknuzzaman ASM; Qusar MMAS; Raihan SZ; Islam MR; Mahmud ZA
PLoS One; 2023; 18(11):e0294288. PubMed ID: 37967104
[TBL] [Abstract][Full Text] [Related]
17. Changes in peripheral blood compounds following psychopharmacological treatment in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis.
Çakici N; Sutterland AL; Penninx BWJH; de Haan L; van Beveren NJM
Psychol Med; 2021 Mar; 51(4):538-549. PubMed ID: 33653423
[TBL] [Abstract][Full Text] [Related]
18. Neuropsychological Assessments of Cognitive Impairment in Major Depressive Disorder: A Systematic Review and Meta-Analysis with Meta-Regression.
Rhee TG; Shim SR; Manning KJ; Tennen HA; Kaster TS; d'Andrea G; Forester BP; Nierenberg AA; McIntyre RS; Steffens DC
Psychother Psychosom; 2024; 93(1):8-23. PubMed ID: 38272009
[TBL] [Abstract][Full Text] [Related]
19. Peripheral Alterations in Cytokine and Chemokine Levels After Antidepressant Drug Treatment for Major Depressive Disorder: Systematic Review and Meta-Analysis.
Köhler CA; Freitas TH; Stubbs B; Maes M; Solmi M; Veronese N; de Andrade NQ; Morris G; Fernandes BS; Brunoni AR; Herrmann N; Raison CL; Miller BJ; Lanctôt KL; Carvalho AF
Mol Neurobiol; 2018 May; 55(5):4195-4206. PubMed ID: 28612257
[TBL] [Abstract][Full Text] [Related]
20. Cancer-related inflammation and depressive symptoms: Systematic review and meta-analysis.
McFarland DC; Doherty M; Atkinson TM; O'Hanlon R; Breitbart W; Nelson CJ; Miller AH
Cancer; 2022 Jul; 128(13):2504-2519. PubMed ID: 35417925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
